Updated:
Linden Lake Venture Capital
Linden Lake Venture Capital focuses on investing in biotechnology companies developing new molecular medicines. The firm has made two investments to date.
Linden Lake Venture Capital
Linden Lake Venture Capital focuses on investing in biotechnology companies developing new molecular medicines. The firm has made two investments to date. Its most recent investment was in CrossBridge Bio, a Seed VC investment made on November 04, 2024.
General information
Firm type
Venture Capital
Year founded
2019
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Sector focus
Frequently asked questions
Which sectors does Linden Lake Venture Capital prioritize?
The firm invests primarily in enterprise technology, with a sector emphasis that includes enterprise software, cybersecurity, artificial intelligence and machine learning, and digital health. Its proximity to federal technology buyers in the Washington, D.C. corridor informs this focus.
How does Linden Lake Venture Capital's location influence its investment strategy?
Operating from Bethesda, Maryland, Linden Lake benefits from proximity to the Washington, D.C. technology corridor. This region hosts a dense concentration of government-focused IT contractors, federal labs, and dual-use technology companies, creating a distinctive sourcing advantage for the firm.
Who are the investment decision-makers at Linden Lake Venture Capital?
The firm does not publicly disclose its principals or investment committee structure. Allocators should inquire directly about key decision-makers and their backgrounds during due diligence.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: